Breaking News

NEW YORK, Nov. 29 — The Institute for Genomics Research is creating a Pathogen Functional Genomics Resource Center with a $25 million, five-year contract from NIH’s National Institute for Allergy and Infectious Diseases.

NEW YORK, Nov. 29 – A Boston jury found that Waters Corporation infringed upon a patent for high throughput liquid chromatography held by Cohesive Technologies, the companies announced Thursday.

NEW YORK, Nov.

NEW YORK, Nov. 28—Researchers at The Institute for Genomic Research (TIGR) have sequenced the anthrax genome, The New York Times reported today.

SAN FRANCISCO, Nov. 28 – Millennium Pharmaceuticals on Tuesday announced it had begun Phase I clinical trials for its first molecule directed against a genomically- derived target for metabolic disease.

NEW YORK, Nov. 28—Japanese pharmaceutical giant Takeda said Wednesday that it would build a 27,000 square meter research facility dedicated to genomics-based drug discovery research.

SAN FRANCISCO, Nov. 28 – Contending patent violations, Incyte Genomics filed suit against Invitrogen on Nov. 21 in the US District Court of the Southern District of California.

NEW YORK, Nov. 28 – Biotechnology company Pluvita has signed a three-year, non-exclusive deal for access to AxCell Bioscience’s ProChart database, which contains information on signal transduction pathways in the human proteome, AxCell said Wednesday.

NEW YORK, Nov. 28 — Despite current economic conditions, Applied Biosystems remains optimistic about prospects for instrument sales, according to Stephen Lombardi, the company's vice president of applications and products.

NEW YORK, Nov. 28 - IBM and Lion Bioscience said on Wednesday that they signed a deal to combine their technologies and jointly market the new offering.

NEW YORK, Nov. 26 - Rosetta Biosoftware announced on Monday that it has licensed its Resolver gene-expression data-analysis system to COR Therapeutics.

NEW YORK, Nov. 26 — GPC Biotech has signed an agreement to allow ICOS Corporation to develop and manufacture its anti-MHC class II antibody products, GPC said on Monday.

NEW YORK, Nov. 26 - GenoMed said on Monday that it has finalized a letter of intent to acquire Genomic Medicine in an all-stock transaction that is set to close within 10 days.

Pages

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.